Patents by Inventor David H. Singleton

David H. Singleton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel inhibitor of beta amyloid cleavage enzyme
    Publication number: 20020115616
    Abstract: This invention relates to a novel inhibitor of beta amyloid cleavage enzyme (BACE, transmembrane aspartyl protease beta-secretase, beta site APP cleavage enzyme, memapsin-2, BACE-1), pharmaceutical compositions containing it and its use in the treatment of neurological disorders such as Alzheimer's disease, Crutzfield-Jacob's disease, prion disorders, amyotrophic lateral sclerosis, progressive supranuclear palsy, head trauma, stroke, down's syndrome, pancreatitis, inclusion body myocitis, other peripheral amyloidoses and diabetes.
    Type: Application
    Filed: February 14, 2002
    Publication date: August 22, 2002
    Applicant: Pfizer Inc.
    Inventors: James G. Boyd, David H. Singleton